Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manu Shankar

Showing results (11-20 of 238) with videos related to

Pageof 24
Sort By:
JAMA|February 18, 2020
Lack of Clinical Benefit of Interferon β-1a Among Patients With Severe Acute Respiratory Distress Syndrome: Time to Overhaul Drug Trials in ARDS?Manu Shankar-Hari, Carolyn S Calfee
Critical Care Medicine|October 14, 2017
Just Because Things Are Not Different, Does Not Mean They Are the Same: Biomarker Patterns in Acute Respiratory Distress SyndromeManu Shankar-Hari, Gordon D Rubenfeld
Expert Review of Molecular Diagnostics|March 22, 2014
How might a diagnostic microRNA signature be used to speed up the diagnosis of sepsis?Manu Shankar-Hari, Graham M Lord
Current Infectious Disease Reports|October 7, 2016
Understanding Long-Term Outcomes Following Sepsis: Implications and ChallengesManu Shankar-Hari, Gordon D Rubenfeld
Current Opinion in Critical Care|July 24, 2019
Population enrichment for critical care trials: phenotypes and differential outcomesManu Shankar-Hari, Gordon D Rubenfeld
American Journal of Respiratory and Critical Care Medicine|February 2, 2017
Acute Respiratory Distress Syndrome Phenotypes and Identifying Treatable Traits. The Dawn of Personalized Medicine for ARDSManu Shankar-Hari, Daniel F McAuley
Chest|February 20, 2021
Immunological Subpopulations Within Critically Ill COVID-19 PatientsJulie Kay Wilson, Manu Shankar-Hari
JAMA|October 26, 2018
Lessons From ARDS for Non-ARDS Research: Remembrance of Trials PastGordon D Rubenfeld, Manu Shankar-Hari
Thorax|July 19, 2017
Divide and conquer: identifying acute respiratory distress syndrome subphenotypesManu Shankar-Hari, Daniel F McAuley
Critical Care Medicine|May 16, 2018
Race, Ethnicity, and Sepsis: Beyond Adjusted Odds RatiosManu Shankar-Hari, Gordon D Rubenfeld
Pageof 24

Showing results (11-20 of 238) with videos related to

Sort By:
Pageof 24
JAMA|February 18, 2020
Lack of Clinical Benefit of Interferon β-1a Among Patients With Severe Acute Respiratory Distress Syndrome: Time to Overhaul Drug Trials in ARDS?Manu Shankar-Hari, Carolyn S Calfee
Critical Care Medicine|October 14, 2017
Just Because Things Are Not Different, Does Not Mean They Are the Same: Biomarker Patterns in Acute Respiratory Distress SyndromeManu Shankar-Hari, Gordon D Rubenfeld
Expert Review of Molecular Diagnostics|March 22, 2014
How might a diagnostic microRNA signature be used to speed up the diagnosis of sepsis?Manu Shankar-Hari, Graham M Lord
Current Infectious Disease Reports|October 7, 2016
Understanding Long-Term Outcomes Following Sepsis: Implications and ChallengesManu Shankar-Hari, Gordon D Rubenfeld
Current Opinion in Critical Care|July 24, 2019
Population enrichment for critical care trials: phenotypes and differential outcomesManu Shankar-Hari, Gordon D Rubenfeld
American Journal of Respiratory and Critical Care Medicine|February 2, 2017
Acute Respiratory Distress Syndrome Phenotypes and Identifying Treatable Traits. The Dawn of Personalized Medicine for ARDSManu Shankar-Hari, Daniel F McAuley
Chest|February 20, 2021
Immunological Subpopulations Within Critically Ill COVID-19 PatientsJulie Kay Wilson, Manu Shankar-Hari
JAMA|October 26, 2018
Lessons From ARDS for Non-ARDS Research: Remembrance of Trials PastGordon D Rubenfeld, Manu Shankar-Hari
Thorax|July 19, 2017
Divide and conquer: identifying acute respiratory distress syndrome subphenotypesManu Shankar-Hari, Daniel F McAuley
Critical Care Medicine|May 16, 2018
Race, Ethnicity, and Sepsis: Beyond Adjusted Odds RatiosManu Shankar-Hari, Gordon D Rubenfeld
Pageof 24